Our Mission is to reduce death and disability from cardiovascular disease, diabetes and related conditions through research, education and health care delivery.
This study will help us understand the bacteria present in people with high blood pressure.
Trialing prescription drugs to activate brown adipose tissue as a possible treatment for obesity
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
Specialists are warning against apathy toward CVD research in light of an apparent ‘disease fatigue’ that has robbed the sector of funding momentum. Find out more
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.Find out more